Stop under-reporting outcomes of drug reaction – FDA
The National Pharmacovigilance Centre of the Food and Drugs Authority (FDA) has expressed concern about the reluctance of the nation’s health facilities to report outcomes of adverse drug reaction (ADR), experienced by their patients.…